메뉴 건너뛰기




Volumn 10, Issue , 2012, Pages

Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review

Author keywords

Androgen suppression therapy; Gynecomastia; Meta analysis; Prostatic neoplasms; Systematic review; Tamoxifen

Indexed keywords

ANASTROZOLE; ANTIANDROGEN; BICALUTAMIDE; TAMOXIFEN;

EID: 84865345095     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-96     Document Type: Article
Times cited : (23)

References (39)
  • 1
    • 0036636871 scopus 로고    scopus 로고
    • Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941
    • 10.1016/S0022-5347(05)64820-3, 12050481
    • Huggins C, Hodges CV. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 2002, 168:9-12. 10.1016/S0022-5347(05)64820-3, 12050481.
    • (2002) J Urol , vol.168 , pp. 9-12
    • Huggins, C.1    Hodges, C.V.2
  • 3
    • 0035152026 scopus 로고    scopus 로고
    • Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function
    • 10.1046/j.1464-410x.2001.00988.x, 11121992
    • Iversen P, Melezinek I, Schmidt A. Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function. BJU Int 2001, 87:47-56. 10.1046/j.1464-410x.2001.00988.x, 11121992.
    • (2001) BJU Int , vol.87 , pp. 47-56
    • Iversen, P.1    Melezinek, I.2    Schmidt, A.3
  • 4
    • 0036448932 scopus 로고    scopus 로고
    • Bicalutamide: in early-stage prostate cancer
    • discussion 2480-2471, 10.2165/00003495-200262170-00006, 12421104
    • Carswell CI, Figgitt DP. Bicalutamide: in early-stage prostate cancer. Drugs 2002, 62:2471-2479. discussion 2480-2471, 10.2165/00003495-200262170-00006, 12421104.
    • (2002) Drugs , vol.62 , pp. 2471-2479
    • Carswell, C.I.1    Figgitt, D.P.2
  • 5
    • 0033789619 scopus 로고    scopus 로고
    • Gynecomastia in patients with prostate cancer: a review of treatment options
    • 10.1016/S0090-4295(00)00823-2, 11068286
    • McLeod DG, Iversen P. Gynecomastia in patients with prostate cancer: a review of treatment options. Urology 2000, 56:713-720. 10.1016/S0090-4295(00)00823-2, 11068286.
    • (2000) Urology , vol.56 , pp. 713-720
    • McLeod, D.G.1    Iversen, P.2
  • 6
    • 5444248630 scopus 로고    scopus 로고
    • Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years
    • 10.1097/01.ju.0000140159.94703.80, 15540740
    • Wirth MP, See WA, McLeod DG, Iversen P, Morris T, Carroll K. Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. J Urol 2004, 172:1865-1870. 10.1097/01.ju.0000140159.94703.80, 15540740.
    • (2004) J Urol , vol.172 , pp. 1865-1870
    • Wirth, M.P.1    See, W.A.2    McLeod, D.G.3    Iversen, P.4    Morris, T.5    Carroll, K.6
  • 7
    • 33644857333 scopus 로고    scopus 로고
    • Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
    • 10.1111/j.1464-410X.2005.06051.x, 16430622
    • McLeod DG, Iversen P, See WA, Morris T, Armstrong J, Wirth MP. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. BJU Int 2006, 97:247-254. 10.1111/j.1464-410X.2005.06051.x, 16430622.
    • (2006) BJU Int , vol.97 , pp. 247-254
    • McLeod, D.G.1    Iversen, P.2    See, W.A.3    Morris, T.4    Armstrong, J.5    Wirth, M.P.6
  • 9
    • 20944447546 scopus 로고    scopus 로고
    • Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial
    • 10.1016/S1470-2045(05)70103-0, 15863377
    • Perdona S, Autorino R, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Bianco AR, Di Lorenzo G. Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol 2005, 6:295-300. 10.1016/S1470-2045(05)70103-0, 15863377.
    • (2005) Lancet Oncol , vol.6 , pp. 295-300
    • Perdona, S.1    Autorino, R.2    De Placido, S.3    D'Armiento, M.4    Gallo, A.5    Damiano, R.6    Pingitore, D.7    Gallo, L.8    De Sio, M.9    Bianco, A.R.10    Di Lorenzo, G.11
  • 10
    • 0031451419 scopus 로고    scopus 로고
    • Tamoxifen for flutamide/finasteride-induced gynecomastia
    • 10.1016/S0090-4295(97)00457-3, 9426725
    • Staiman VR, Lowe FC. Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology 1997, 50:929-933. 10.1016/S0090-4295(97)00457-3, 9426725.
    • (1997) Urology , vol.50 , pp. 929-933
    • Staiman, V.R.1    Lowe, F.C.2
  • 11
    • 0022453573 scopus 로고
    • Treatment of gynecomastia with tamoxifen: A double-blind crossover study
    • 10.1016/0026-0495(86)90237-4, 3526085
    • Parker LN, Gray DR, Lai MK, Levin ER. Treatment of gynecomastia with tamoxifen: A double-blind crossover study. Metabolism 1986, 35:705-708. 10.1016/0026-0495(86)90237-4, 3526085.
    • (1986) Metabolism , vol.35 , pp. 705-708
    • Parker, L.N.1    Gray, D.R.2    Lai, M.K.3    Levin, E.R.4
  • 12
    • 34249001119 scopus 로고    scopus 로고
    • Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study
    • 10.1016/j.eururo.2007.01.031, 17270340
    • Fradet Y, Egerdie B, Andersen M, Tammela TLJ, Nachabe M, Armstrong J, Morris T, Navani S. Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study. Eur Urol 2007, 52:106-114. 10.1016/j.eururo.2007.01.031, 17270340.
    • (2007) Eur Urol , vol.52 , pp. 106-114
    • Fradet, Y.1    Egerdie, B.2    Andersen, M.3    Tammela, T.L.J.4    Nachabe, M.5    Armstrong, J.6    Morris, T.7    Navani, S.8
  • 13
    • 17844367225 scopus 로고    scopus 로고
    • Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole
    • 10.1038/sj.pcan.4500782, 15685254
    • Saltzstein D, Sieber P, Morris T, Gallo J. Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer Prostatic Dis 2005, 8:75-83. 10.1038/sj.pcan.4500782, 15685254.
    • (2005) Prostate Cancer Prostatic Dis , vol.8 , pp. 75-83
    • Saltzstein, D.1    Sieber, P.2    Morris, T.3    Gallo, J.4
  • 14
    • 34249042924 scopus 로고    scopus 로고
    • Bicalutamide-induced gynaecomastia: do we have the answer?
    • 10.1016/j.eururo.2007.01.063, 17258386
    • Di Lorenzo G, Autorino R. Bicalutamide-induced gynaecomastia: do we have the answer?. Eur Urol 2007, 52:5-8. 10.1016/j.eururo.2007.01.063, 17258386.
    • (2007) Eur Urol , vol.52 , pp. 5-8
    • Di Lorenzo, G.1    Autorino, R.2
  • 15
    • 28044452182 scopus 로고    scopus 로고
    • Management of gynaecomastia in patients with prostate cancer: a systematic review
    • 10.1016/S1470-2045(05)70464-2, 16321765
    • Di Lorenzo G, Autorino R, Perdona S, De Placido S. Management of gynaecomastia in patients with prostate cancer: a systematic review. Lancet Oncol 2005, 6:972-979. 10.1016/S1470-2045(05)70464-2, 16321765.
    • (2005) Lancet Oncol , vol.6 , pp. 972-979
    • Di Lorenzo, G.1    Autorino, R.2    Perdona, S.3    De Placido, S.4
  • 18
    • 23244448028 scopus 로고    scopus 로고
    • Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer
    • 10.1007/s00280-005-1016-1, 15838655
    • Boccardo F, Rubagotti A, Conti G, Potenzoni D, Manganelli A, Del Monaco D. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer. Cancer Chemother Pharmacol 2005, 56:415-420. 10.1007/s00280-005-1016-1, 15838655.
    • (2005) Cancer Chemother Pharmacol , vol.56 , pp. 415-420
    • Boccardo, F.1    Rubagotti, A.2    Conti, G.3    Potenzoni, D.4    Manganelli, A.5    Del Monaco, D.6
  • 21
    • 27744476741 scopus 로고    scopus 로고
    • Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy
    • 10.1097/01.ju.0000181824.28382.5c, 16280763
    • Di Lorenzo G, Perdona S, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Autorino R. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy. J Urol 2005, 174:2197-2203. 10.1097/01.ju.0000181824.28382.5c, 16280763.
    • (2005) J Urol , vol.174 , pp. 2197-2203
    • Di Lorenzo, G.1    Perdona, S.2    De Placido, S.3    D'Armiento, M.4    Gallo, A.5    Damiano, R.6    Pingitore, D.7    Gallo, L.8    De Sio, M.9    Autorino, R.10
  • 22
    • 0242542209 scopus 로고    scopus 로고
    • Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynaecomastia and breast pain
    • Saltzstein D, Cantwell A, Sieber P, Ross JR, Silvay-Mandeau O, Gallo J. Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynaecomastia and breast pain. BJU Int 2002, 90(Suppl 2):119-122.
    • (2002) BJU Int , vol.90 , Issue.SUPPL. 2 , pp. 119-122
    • Saltzstein, D.1    Cantwell, A.2    Sieber, P.3    Ross, J.R.4    Silvay-Mandeau, O.5    Gallo, J.6
  • 23
    • 84867139635 scopus 로고    scopus 로고
    • An open, randomized, multicentre, phase III trial comparing the efficacy of two tamoxifen (T) schedules in preventing gynecomastia (gy) induced by bicalutamide monotherapy (BM) in prostate cancer patients (pca pts)
    • Bedognetti D, Rubagotti A, Conti G, Francesca F, De Cobelli O, Canclini L, Galucci F, Aragona F, Di Tonno P, Boccardo F. An open, randomized, multicentre, phase III trial comparing the efficacy of two tamoxifen (T) schedules in preventing gynecomastia (gy) induced by bicalutamide monotherapy (BM) in prostate cancer patients (pca pts). J Clin Oncol 2009, 27:e16080.
    • (2009) J Clin Oncol , vol.27
    • Bedognetti, D.1    Rubagotti, A.2    Conti, G.3    Francesca, F.4    De Cobelli, O.5    Canclini, L.6    Galucci, F.7    Aragona, F.8    Di Tonno, P.9    Boccardo, F.10
  • 24
    • 72149085457 scopus 로고    scopus 로고
    • An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients
    • 10.1016/j.eururo.2009.05.019, 19481335
    • Bedognetti D, Rubagotti A, Conti G, Francesca F, De Cobelli O, Canclini L, Gallucci M, Aragona F, Di Tonno P, Cortellini P, Martorana G, Lapini A, Boccardo F. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients. Eur Urol 2010, 57:238-245. 10.1016/j.eururo.2009.05.019, 19481335.
    • (2010) Eur Urol , vol.57 , pp. 238-245
    • Bedognetti, D.1    Rubagotti, A.2    Conti, G.3    Francesca, F.4    De Cobelli, O.5    Canclini, L.6    Gallucci, M.7    Aragona, F.8    Di Tonno, P.9    Cortellini, P.10    Martorana, G.11    Lapini, A.12    Boccardo, F.13
  • 27
    • 34249295965 scopus 로고    scopus 로고
    • Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study
    • 10.1016/j.eururo.2007.01.032, 17270341
    • Van Poppel H. Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study. Eur Urol 2007, 52:115. 10.1016/j.eururo.2007.01.032, 17270341.
    • (2007) Eur Urol , vol.52 , pp. 115
    • Van Poppel, H.1
  • 28
    • 42049100517 scopus 로고    scopus 로고
    • Plastic surgery for the treatment of gynaecomastia following hormone therapy in prostate carcinoma
    • 10.1007/s00120-007-1567-3, 18210077
    • Ryssel H, Germann G, Kollensperger E, Riedel K. Plastic surgery for the treatment of gynaecomastia following hormone therapy in prostate carcinoma. Urologe A 2008, 47:467-471. 10.1007/s00120-007-1567-3, 18210077.
    • (2008) Urologe A , vol.47 , pp. 467-471
    • Ryssel, H.1    Germann, G.2    Kollensperger, E.3    Riedel, K.4
  • 30
    • 0037253622 scopus 로고    scopus 로고
    • Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3
    • 10.1016/S0090-4295(02)02107-6, 12559286
    • Widmark A, Fossa SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O. Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology 2003, 61:145-151. 10.1016/S0090-4295(02)02107-6, 12559286.
    • (2003) Urology , vol.61 , pp. 145-151
    • Widmark, A.1    Fossa, S.D.2    Lundmo, P.3    Damber, J.E.4    Vaage, S.5    Damber, L.6    Wiklund, F.7    Klepp, O.8
  • 32
    • 0022572502 scopus 로고
    • Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequela
    • Fass D, Steinfeld A, Brown J, Tessler A. Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequela. Int J Radiation Oncology Biol Phys 1986, 12:407-408.
    • (1986) Int J Radiation Oncology Biol Phys , vol.12 , pp. 407-408
    • Fass, D.1    Steinfeld, A.2    Brown, J.3    Tessler, A.4
  • 33
    • 17144409402 scopus 로고    scopus 로고
    • Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer
    • 10.1016/j.eururo.2004.12.003, 15826748
    • Van Poppel H, Tyrrell CJ, Haustermans K, Cangh PV, Keuppens F, Colombeau P, Morris T, Garside L. Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer. Eur Urol 2005, 47:587-592. 10.1016/j.eururo.2004.12.003, 15826748.
    • (2005) Eur Urol , vol.47 , pp. 587-592
    • Van Poppel, H.1    Tyrrell, C.J.2    Haustermans, K.3    Cangh, P.V.4    Keuppens, F.5    Colombeau, P.6    Morris, T.7    Garside, L.8
  • 34
    • 0037241913 scopus 로고    scopus 로고
    • The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy
    • 10.1016/S1470-2045(03)00958-6, 12517537
    • Dicker AP. The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy. Lancet Oncol 2003, 4:30-36. 10.1016/S1470-2045(03)00958-6, 12517537.
    • (2003) Lancet Oncol , vol.4 , pp. 30-36
    • Dicker, A.P.1
  • 35
    • 39749176174 scopus 로고    scopus 로고
    • Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?
    • 10.1186/1748-717X-3-2, 2249590, 18186924
    • Nieder C, Pawinski A, Andratschke NH, Molls M. Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?. Radiat Oncol 2008, 3:2. 10.1186/1748-717X-3-2, 2249590, 18186924.
    • (2008) Radiat Oncol , vol.3 , pp. 2
    • Nieder, C.1    Pawinski, A.2    Andratschke, N.H.3    Molls, M.4
  • 36
    • 0037316419 scopus 로고    scopus 로고
    • Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction
    • discussion 924-905, 10.1097/01.PRS.0000042146.40379.25, 12560721
    • Rohrich RJ, Ha RY, Kenkel JM, Adams WP. Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction. Plast Reconstr Surg 2003, 111:909-923. discussion 924-905, 10.1097/01.PRS.0000042146.40379.25, 12560721.
    • (2003) Plast Reconstr Surg , vol.111 , pp. 909-923
    • Rohrich, R.J.1    Ha, R.Y.2    Kenkel, J.M.3    Adams, W.P.4
  • 37
    • 33747052557 scopus 로고    scopus 로고
    • Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients
    • Boccardo F, Rubagotti A, Battaglia M, Zattoni F, Bertaccini A, Romagnoli A, Conti G. Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients. Int J Biol Markers 2006, 21:123-126.
    • (2006) Int J Biol Markers , vol.21 , pp. 123-126
    • Boccardo, F.1    Rubagotti, A.2    Battaglia, M.3    Zattoni, F.4    Bertaccini, A.5    Romagnoli, A.6    Conti, G.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.